Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study

Publikation

Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study

Wissenschaftlicher Artikel/Review - 18.10.2010

Young J, Bucher Hc, Battegay M, Hirschel B, Vernazza Pietro, Bernasconi E, Cavassini M, Fux Ca, Rickenbach M, Böni J, Yerly S, Opravil M, Günthard Hf, Scherrer Au, for the Swiss HIV Cohort Study

Young, J

Scherrer, Au

Günthard, Hf

Opravil, M

Yerly, S

Böni, J

Rickenbach, M

Fux, Ca

Cavassini, M

Bernasconi, E

Vernazza, Pietro

279

Hirschel, B

Battegay, M

Bucher, Hc

for the Swiss HIV Cohort Study,